5.46 - 5.56
4.95 - 8.28
1.7K / 2.4K (Avg.)
-276.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.85%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-16.31%
Negative gross profit growth while HUH1V.HE is at 10.67%. Joel Greenblatt would examine cost competitiveness or demand decline.
-89.49%
Negative EBIT growth while HUH1V.HE is at 66.21%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-89.49%
Negative operating income growth while HUH1V.HE is at 66.21%. Joel Greenblatt would press for urgent turnaround measures.
-76.26%
Negative net income growth while HUH1V.HE stands at 75.10%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-76.43%
Negative EPS growth while HUH1V.HE is at 75.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-76.43%
Negative diluted EPS growth while HUH1V.HE is at 75.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.28%
Share change of 0.28% while HUH1V.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.28%
Diluted share change of 0.28% while HUH1V.HE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
391.03%
OCF growth above 1.5x HUH1V.HE's 96.13%. David Dodd would confirm a clear edge in underlying cash generation.
191.44%
FCF growth 50-75% of HUH1V.HE's 331.80%. Martin Whitman would see if structural disadvantages exist in generating free cash.
-3.24%
Negative 10Y revenue/share CAGR while HUH1V.HE stands at 74.20%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
2.12%
5Y revenue/share CAGR under 50% of HUH1V.HE's 32.68%. Michael Burry would suspect a significant competitive gap or product weakness.
3.58%
3Y revenue/share CAGR under 50% of HUH1V.HE's 22.19%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
793.33%
10Y OCF/share CAGR above 1.5x HUH1V.HE's 230.87%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
43.94%
Below 50% of HUH1V.HE's 360.03%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
4.91%
3Y OCF/share CAGR under 50% of HUH1V.HE's 33.83%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-33.77%
Negative 10Y net income/share CAGR while HUH1V.HE is at 64.05%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-91.72%
Negative 5Y net income/share CAGR while HUH1V.HE is 10.18%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-89.81%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
129.33%
10Y equity/share CAGR in line with HUH1V.HE's 136.69%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
48.29%
5Y equity/share CAGR at 75-90% of HUH1V.HE's 56.33%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
44.74%
3Y equity/share CAGR similar to HUH1V.HE's 42.95%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-11.53%
Firm’s AR is declining while HUH1V.HE shows 1.13%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-13.82%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-3.77%
Negative asset growth while HUH1V.HE invests at 1.17%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.31%
We have a declining book value while HUH1V.HE shows 5.85%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-2.03%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-6.32%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.